Cortisol Downregulates Osteoblast Alpha 1 (I) Procollagen MRNA by Transcriptional and Posttranscriptional Mechanisms
Overview
Cell Biology
Authors
Affiliations
Glucocorticoids decrease osteoblast proliferation and type I collagen production, and this may play a role in the development of glucocorticoid-induced osteoporosis. Osteoblast-enriched cultures derived from fetal rat calvaria were used to determine the mechanisms by which cortisol decreases alpha 1 (I) procollagen expression in bone cells. A 24 h treatment with cortisol decreased collagen synthesis in these cultures in a dose-dependent manner. Cortisol decreased alpha 1 (I) procollagen transcripts in a dose- and time-dependent manner as well. Repression of alpha 1 (I) procollagen transcripts was evident as early as 2 h of treatment and was maximal after 48 h of treatment. Nuclear run-off assays showed that cortisol downregulated transcription of the alpha 1 (I) procollagen gene. In addition, pretreatment with cortisol decreased the stability of alpha 1 (I) procollagen mRNA in transcription-arrested osteoblast cultures. The ability of cortisol to downregulate alpha 1 (I) procollagen transcripts was sensitive to cycloheximide treatment, suggesting that the gene is under "secondary control" by glucocorticoids. Since cortisol decreases alpha 1 (I) procollagen gene transcription in osteoblasts but does not affect alpha 1 (I) procollagen gene transcription in fibroblasts, we suggest that the mechanisms controlling glucocorticoid repression of collagen expression are cell-type specific.
Abdullah Sani N, Kamaruddin N, Soelaiman I, Pang K, Chin K, Ramli E Biomedicines. 2025; 13(1).
PMID: 39857826 PMC: 11762645. DOI: 10.3390/biomedicines13010243.
Pathogenic mechanisms of glucocorticoid-induced osteoporosis.
Chen M, Fu W, Xu H, Liu C Cytokine Growth Factor Rev. 2023; 70:54-66.
PMID: 36906448 PMC: 10518688. DOI: 10.1016/j.cytogfr.2023.03.002.
Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes.
Gado M, Baschant U, Hofbauer L, Henneicke H Front Endocrinol (Lausanne). 2022; 13:835720.
PMID: 35432217 PMC: 9008133. DOI: 10.3389/fendo.2022.835720.
The molecular etiology and treatment of glucocorticoid-induced osteoporosis.
Peng C, Lin W, Yeh K, Chen I, Wu W, Lin M Tzu Chi Med J. 2021; 33(3):212-223.
PMID: 34386357 PMC: 8323641. DOI: 10.4103/tcmj.tcmj_233_20.
Sarker H, Hardy E, Haimour A, Karim M, Scholl-Burgi S, Martignetti J Front Physiol. 2020; 11:568718.
PMID: 33101055 PMC: 7546215. DOI: 10.3389/fphys.2020.568718.